New biomarker could track progression of Alzheimer’s disease

FHS
July 14, 2023
12:02 am

Two pathologies drive the progression of Alzheimer’s disease. Early on, amyloid beta plaques lead the way, but around the time cognitive symptoms arise, tau tangles take over as the driving force and cognition steadily declines.

Oregon suspends a portion of its drug transparency law found to be unconstitutional

In a victory for the pharmaceutical industry, Oregon officials have suspended a portion of a contentious state law designed to bring more transparency to prescription

February 23, 2024

Microsoft is selling AI in health care, and helping to set its standards. Is that a problem?

For a company moving as quickly as possible to build artificial intelligence into everything — including health care — Microsoft spends a lot of time

April 18, 2024

achieves further growth in the first half of 2023 and expects strong third quarter – Biotech Investments

EQS-News: Medios AG / Key word(s): Half Year Report/Half Year Results Medios AG: achieves further growth in the first half of 2023 and expects strong

August 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.